Page 3 - Quarter For Jazz Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quarter for jazz pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quarter For Jazz Pharmaceuticals Today - Breaking & Trending Today

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) EVP Sells $548,250.00 in Stock

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) EVP Sells $548,250.00 in Stock
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Neenam Patil , Piper Sandler , Cape Investment Advisory Inc , Rise Advisors , Jazz Pharmaceuticals Company Profile , Royal Bank , News Ratings For Jazz Pharmaceuticals Daily , Covestor Ltd , Jazz Pharmaceuticals , Jpmorgan Chase Co , Institutional Investors Weigh In On Jazz Pharmaceuticals , Jazz Pharmaceuticals Price Performance , Quarter For Jazz Pharmaceuticals , Get Free Report , Investment Advisory , Wealth Management , Jazz Pharmaceuticals Daily ,

Insider Selling: Jazz Pharmaceuticals plc (NASDAQ:JAZZ) EVP Sells $548,250.00 in Stock

Insider Selling: Jazz Pharmaceuticals plc (NASDAQ:JAZZ) EVP Sells $548,250.00 in Stock
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Neenam Patil , Jazz Pharmaceuticals Stock Performance , Institutional Trading Of Jazz Pharmaceuticals , Quarter For Jazz Pharmaceuticals , Jpmorgan Chase Co , Cantor Fitzgerald , Jazz Pharmaceuticals , Royal Bank , News Ratings For Jazz Pharmaceuticals Daily , Polaris Capital Management , Ameriprise Financial Inc , Jazz Pharmaceuticals Company Profile , Vanguard Group Inc , Get Free Report , Capital Management , Ameriprise Financial , Jazz Pharmaceuticals Daily ,

Todd Asset Management LLC Sells 4,977 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Todd Asset Management LLC cut its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 2.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 170,233 shares of the specialty pharmaceutical company’s stock after selling 4,977 shares during the period. Todd […] ....

United States , Philipl Johnson , Stifel Nicolaus , Patricia Carr , Piper Sandler , Todd Asset Management , Exchange Commission , Quarter For Jazz Pharmaceuticals , Jazz Pharmaceuticals Price Performance , Securities Exchange Commission , Cantor Fitzgerald , Headlands Technologies , Jazz Pharmaceuticals , Royal Bank , News Ratings For Jazz Pharmaceuticals Daily , Covestor Ltd , Free Report , Asset Management , Wealth Management , Get Free Report , Visit Holdingschannel , Jazz Pharmaceuticals Daily , Nasdaq Jazz , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Eukles Asset Management Sells 144 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Eukles Asset Management reduced its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 6.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,180 shares of the specialty pharmaceutical company’s stock after selling 144 shares during the quarter. Eukles Asset Management’s holdings […] ....

New Zealand General , New Zealand , United States , Robertw Baird , Philipl Johnson , Patricia Carr , Royal Bank , Jazz Pharmaceuticals , Needham Company , Securities Exchange Commission , Exchange Commission , Wellington Management Group , Jazz Pharmaceuticals Price Performance , Quarter For Jazz Pharmaceuticals , Vanguard Group Inc , News Ratings For Jazz Pharmaceuticals Daily , Eukles Asset Management , Free Report , Asset Management , Management Group , Street Corp , Get Free Report , Visit Holdingschannel , Jazz Pharmaceuticals Daily ,

Eukles Asset Management Reduces Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Eukles Asset Management trimmed its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 6.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,180 shares of the specialty pharmaceutical company’s stock after selling 144 shares during the period. Eukles […] ....

United States , Patricia Carr , Piper Sandler , Stifel Nicolaus , Philipl Johnson , Covestor Ltd , Jazz Pharmaceuticals Price Performance , News Ratings For Jazz Pharmaceuticals Daily , Insider Activity At Jazz Pharmaceuticals , Quarter For Jazz Pharmaceuticals , Needham Company , Cantor Fitzgerald , Jazz Pharmaceuticals , Headlands Technologies , Securities Exchange Commission , Jazz Pharmaceuticals Profile , Eukles Asset Management , Free Report , Asset Management , Wealth Management , Get Free Report , Exchange Commission , Visit Holdingschannel , Jazz Pharmaceuticals Daily ,